Drug Manufacturers - Specialty & Generic stocks
Every US Drug Manufacturers - Specialty & Generic company with filed annual reports: 68, in the Healthcare sector, with the ratios the screener prints. A name opens the company’s page, where every filed figure carries the filing it was read from and every price the day of its close.
Medians across Drug Manufacturers - Specialty & Generic companies
- Price to earnings
- 19.89x of 24
- Price to book
- 1.65x of 48
- Enterprise value to EBIT
- 16.68x of 15
- Free cash flow yield
- 2.4% of 49
- Return on invested capital, after tax
- 3.1% of 21
- Debt to equity
- 0.33 of 33
- Dividend yield
- 2.7% of 7
The companies
| Company | Market cap | P/E | P/B | EV/EBIT | FCF yld | ROIC | D/E | Div yld |
|---|---|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited TAK | 61.73B | 90.42x | 1.41x | 42.22x | 8.8% | 1.8% | 0.73 | n/a |
| Teva Pharmaceutical Industries Limited TEVA | 47.91B | 33.42x | 6.04x | n/a | 2.4% | n/a | n/a | n/a |
| Haleon plc HLN | 43.71B | 19.76x | 2.01x | 16.68x | 7.0% | 7.9% | 0.52 | n/a |
| Zoetis Inc. ZTS | 32.41B | 13.00x | 10.19x | 11.63x | 6.6% | 27.8% | 2.72 | 2.7% |
| Viatris Inc. VTRS | 20.93B | n/m | 1.42x | n/a | 9.3% | -9.1% | 1.00 | 2.6% |
| Neurocrine Biosciences, Inc. NBIX | 13.92B | 28.47x | 4.32x | n/a | 5.3% | n/a | n/a | n/a |
| Elanco Animal Health Incorporated ELAN | 11.76B | n/m | 1.78x | n/a | 2.4% | n/a | 0.67 | n/a |
| Dr. Reddy's Laboratories Limited RDY | 10.74B | 17.99x | 3.05x | 14.61x | 1.9% | 14.7% | 0.14 | n/a |
| Lantheus Holdings, Inc. LNTH | 6.53B | 28.90x | 6.28x | 22.87x | 5.2% | 17.1% | 0.57 | n/a |
| Amneal Pharmaceuticals, Inc. AMRX | 6.15B | 83.70x | n/m | 21.97x | 4.3% | 15.5% | n/m | n/a |
| Regencell Bioscience Holdings Limited RGC | 4.72B | n/m | 353.64x | n/a | n/a | n/m | 0.02 | n/a |
| Indivior Pharmaceuticals Inc INDV | 4.20B | 20.01x | n/m | 17.02x | -2.2% | 396.9% | n/m | 0.0% |
| HUTCHMED (China) Limited HCM | 2.43B | 5.32x | 1.96x | n/a | -3.2% | -2.6% | 0.10 | n/a |
| Bausch Health Companies Inc. BHC | 2.36B | 15.02x | n/m | 12.19x | 42.4% | 3.1% | n/m | n/a |
| Supernus Pharmaceuticals, Inc. SUPN | 2.30B | n/m | 2.10x | n/a | 2.1% | n/a | n/a | n/a |
| Perrigo Company plc PRGO | 2.28B | n/m | 0.78x | n/a | 6.4% | n/a | 1.30 | 7.0% |
| Alvotech ALVO | 1.90B | 67.86x | n/m | 40.55x | -6.0% | 1.6% | n/m | n/a |
| ANI Pharmaceuticals, Inc. ANIP | 1.66B | 20.65x | 2.84x | 14.12x | 11.2% | 15.8% | 0.59 | n/a |
| Phibro Animal Health Corporation PAHC | 1.54B | 15.44x | 4.04x | n/a | 0.6% | n/a | n/a | 1.3% |
| Pacira BioSciences, Inc. PCRX | 1.45B | 227.06x | 2.36x | 98.80x | 8.3% | 0.8% | 0.60 | n/a |
| Cronos Group Inc. CRON | 1.18B | n/m | 1.12x | n/a | 0.01% | -1.0% | 0.001 | n/a |
| Amphastar Pharmaceuticals, Inc. AMPH | 1.12B | 12.58x | 1.61x | 12.61x | 9.5% | 8.7% | 0.85 | n/a |
| Harrow Health, Inc. HROW | 1.08B | n/m | 20.15x | n/a | 4.1% | n/a | n/a | n/a |
| Collegium Pharmaceutical, Inc. COLL | 754.6M | 11.71x | 3.05x | n/a | 35.6% | n/a | n/a | n/a |
| Ironwood Pharmaceuticals, Inc. IRWD | 623.0M | 25.13x | n/m | n/a | 20.7% | n/a | n/m | n/a |
| Aquestive Therapeutics, Inc. AQST | 509.6M | n/m | n/m | n/a | -12.2% | n/m | n/m | n/a |
| Evotec SE EVO | 504.4M | n/m | 0.47x | n/a | -22.1% | n/a | 0.46 | n/a |
| Evolus, Inc. EOLS | 500.0M | n/m | n/m | n/a | -9.4% | n/a | n/m | n/a |
| Kamada Ltd. KMDA | 451.7M | 22.37x | 1.68x | n/a | 3.5% | n/a | n/a | n/a |
| Alpha Teknova, Inc. TKNO | 408.0M | n/m | 5.91x | n/a | -2.4% | n/a | 0.41 | n/a |
| Emergent BioSolutions Inc. EBS | 368.1M | 7.33x | 0.78x | n/a | 38.5% | n/a | n/a | n/a |
| Embecta Corp. EMBC | 365.5M | 3.93x | n/m | 6.62x | 48.0% | 29.7% | n/m | 5.0% |
| Tilray Brands, Inc. TLRY | 359.0M | n/m | 0.22x | n/a | n/a | n/a | 0.24 | n/a |
| Canopy Growth Corporation CGC | 311.1M | n/m | 0.45x | n/a | -22.2% | n/a | 0.40 | n/a |
| SNDL Inc. SNDL | 297.8M | n/m | 0.38x | n/a | 13.8% | n/a | n/a | n/a |
| Aurora Cannabis Inc. ACB | 259.6M | 231.54x | 0.65x | 63.83x | -0.8% | 0.7% | 0.15 | n/a |
| Lifecore Biomedical, Inc. LFCR | 244.1M | n/m | 167.84x | n/a | -6.1% | n/a | 105.96 | n/a |
| SIGA Technologies, Inc. SIGA | 229.2M | 9.67x | 1.15x | 3.17x | 18.8% | 40.7% | 0.004 | 18.8% |
| Journey Medical Corporation DERM | 144.7M | n/m | 3.94x | n/a | n/a | n/a | 0.80 | n/a |
| Organogenesis Holdings Inc. ORGO | 142.8M | 6.94x | 0.48x | n/a | -16.9% | n/a | n/a | n/a |
| Cardiol Therapeutics Inc. CRDL | 138.8M | n/m | 11.02x | n/a | -12.1% | n/m | 0.01 | n/a |
| Organigram Global Inc. OGI | 131.4M | n/m | 0.61x | n/a | -0.5% | n/a | n/a | n/a |
| Cumberland Pharmaceuticals Inc. CPIX | 113.0M | n/m | 4.50x | n/a | 4.3% | n/a | n/a | n/a |
| BGM Group Ltd. BGM | 109.0M | n/m | 0.28x | n/a | -3.6% | n/a | n/a | n/a |
| Zhengye Biotechnology Holding Limited ZYBT | 71.1M | n/m | 1.91x | n/a | 2.6% | n/a | 0.30 | n/a |
| Talphera, Inc. TLPH | 55.5M | n/m | 2.66x | n/a | n/a | n/a | n/a | n/a |
| InterCure Ltd. INCR | 55.1M | n/m | 0.43x | n/a | -41.8% | n/a | n/a | n/a |
| Incannex Healthcare Limited IXHL | 34.5M | n/m | 0.50x | n/a | -38.4% | n/a | n/a | n/a |
| Cosmos Health Inc. COSM | 33.9M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Rockwell Medical, Inc. RMTI | 32.2M | n/m | n/a | n/a | n/a | -12.2% | 0.33 | n/a |
| China Pharma Holdings, Inc. CPHI | 30.1M | n/m | n/a | n/a | n/a | n/a | 0.07 | n/a |
| Shuttle Pharmaceuticals Holdings, Inc. SHPH | 26.5M | n/m | n/a | n/a | n/a | n/a | 0.10 | n/a |
| SCYNEXIS, Inc. SCYX | 24.6M | n/m | n/a | n/a | n/a | -53.1% | 0.04 | n/a |
| TherapeuticsMD, Inc. TXMD | 22.3M | n/m | 0.83x | n/a | n/a | n/a | n/a | n/a |
| Aytu BioPharma, Inc. AYTU | 21.8M | n/m | 0.70x | n/a | 13.1% | n/a | 0.34 | n/a |
| Quantum BioPharma Ltd. QNTM | 17.4M | n/a | 2.52x | n/a | n/a | n/a | 0.20 | n/a |
| Biofrontera Inc. BFRI | 12.6M | n/m | 0.82x | n/a | -155.1% | n/a | n/a | n/a |
| Apimeds Pharmaceuticals US, Inc APUS | 6.6M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Sonoma Pharmaceuticals, Inc. SNOA | 5.5M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| cbdMD, Inc. YCBD | 4.0M | n/m | 0.56x | n/a | -40.6% | -37.7% | 0.11 | n/a |
| Gelteq Limited Ordinary Shares GELS | 4.0M | n/m | 0.36x | n/a | -96.7% | n/a | 0.32 | n/a |
| Akanda Corp. AKAN | 3.1M | n/m | 0.73x | n/a | -194.3% | n/a | n/a | n/a |
| Universe Pharmaceuticals Inc. UPC | 2.6M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| RedHill Biopharma Ltd. RDHL | 1.6M | n/m | n/m | n/a | n/m | n/a | n/m | n/a |
| IM Cannabis Corp. IMCC | 803.2K | n/m | n/m | n/a | n/m | n/a | n/m | n/a |
| Sunshine Biopharma, Inc. SBFM | 488.4K | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| PRF Technologies Ltd. PRFX | 68.1K | n/m | 0.01x | n/a | n/m | n/a | n/a | n/a |
| China SXT Pharmaceuticals, Inc. SXTC | 36.7K | n/m | n/a | n/a | n/a | n/a | 0.04 | n/a |
Largest published market value first. No ratio orders this list, and a company whose market value is not published is listed last.
Prices as of 2026-10-15. Ratios recomputed from the filings 2026-10-15. Every ratio passes the same applicability gate as the screener and the research page, with the latest filed fiscal year's statements. A list is not a recommendation: see the limits of what this tool can tell you.